HB 65: Stem Cells
GENERAL BILL by Clemons ; Pigman ; (CO-INTRODUCERS) Bush ; Casello ; Payne
Stem Cells; Establishes patient eligibility criteria & requirements relating to access to & use of investigational stem cell treatments; requires DOH to adopt rules; prohibits governmental interference in such treatments; requires institutional review boards to oversee treatments, keep records, & submit reports; prohibits purchase or sale of stem cells; provides penalties.
Effective Date: 7/1/2019
Last Action: 5/3/2019 House - Died in Health Quality Subcommittee
Bill Text: PDF
Last Action: 5/3/2019 House - Died in Health Quality Subcommittee
Bill Text: PDF
Bill History
| Date | Chamber | Action |
|---|---|---|
| 11/29/2018 | House |
• Filed |
| 1/3/2019 | House |
• Referred to Health Quality Subcommittee; Health Care Appropriations Subcommittee; Health and Human Services Committee -HJ 27 |
| 3/5/2019 | House |
• Introduced -HJ 27 |
| 5/3/2019 | House |
• Indefinitely postponed and withdrawn from consideration • Died in Health Quality Subcommittee |
